California-based Rune Labs, a precision neurology software and data platform company, is partnering with BlueRock Therapeutics, a clinical-stage biopharmaceutical company and subsidiary of Bayer AG, to aid in studying Parkinson's disease.
BlueRock will utilize Rune Labs' clinical development platform, StriveStudy, for clinical trial enrollment, real-world evidence data generation and monitoring...
